You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-Aryl hydrocarbon Receptor (AhR)-IK-175
IK-175

Chemical Structure : IK-175

CAS No.: 2247950-42-9

IK-175 (IK175)

Catalog No.: PC-38860Not For Human Use, Lab Use Only.

IK-175 is a potent, selective and orally active aryl hydrocarbon receptor (AHR) antagonist with IC50 of 91 nM in human HepG2 cells expressing an AHR-dependent DRE-luciferase reporter and stimulated with 80 nM of the AHR agonist VAF347.

Packing Price Stock Quantity
5 mg $188 In stock
10 mg $298 In stock
25 mg $498 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: 99.30% (HPLC) Select Batch:

Biological Activity

IK-175 is a potent, selective and orally active aryl hydrocarbon receptor (AHR) antagonist with IC50 of 91 nM in human HepG2 cells expressing an AHR-dependent DRE-luciferase reporter and stimulated with 80 nM of the AHR agonist VAF347.
IK-175 inhibits AHR activity in experimental systems derived from multiple species including mouse, rat, monkey, and humans.
IK-175 inhibits AHR activity in rodent and human cancer cell lines as well as human and nonhuman primate primary immune cells, with concentration dependent effects on AHR target gene expression and cytokine release.
Orally administered IK-175 dose-dependently blocks ligand stimulated-AHR activation of Cyp1a1 transcription in liver and spleen, demonstrating on-target in vivo activity in mice.
IK-175 alone and in combination with an anti-PD-1 antibody demonstrates significant antitumor activity in syngeneic mouse models of colorectal cancer (CT26.WT) and melanoma (B16-IDO1).

Physicochemical Properties

M.Wt 441.514
Formula C25H24FN7
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine

References

1. Karen McGovern, et al. Mol Cancer Ther. 2022 Jun 6;molcanther.0984.2021-12-8 12:58:05.173.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: